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Abstract
Background: A previous study based on NHANES 2001–2002 observed that increased levels of urinary perchlorate were associated 
with increased levels of thyroid stimulating hormone among all women, and with decreased levels of thyroxine among women with low 
urinary iodine. No associations were observed for men.
Methods: Using the same NHANES 2001–2002 data, associations of urinary perchlorate with indirect biomarkers of thyroid hormone 
disruption were investigated. Decreased levels of hemoglobin (HGB), hematocrit (HCT), and high density lipoprotein (HDL) have been 
observed among subjects with subclinical hypothyroidism. To investigate the suitability of these indicators for use in observational 
  studies, subjects were divided into six groups: boys, age 6–19; men, age 20–85; girls, age 6–14; non-pregnant women, age 15–49; 
women, age 50–85; and pregnant women. Use of perchlorate quintiles (Q1-Q5) and continuous log-transformed perchlorate in the 
regression models allowed investigation of both non-linear and linear associations. Adjustments were made for age, urinary creatinine, 
race/ethnicity, body mass index, cotinine, poverty index, hours of fasting, thiocyanate, nitrate, daily kcal intake, C-reactive protein. 
Adjustment for alcohol consumption depended on availability. Adjustment for prescription drugs (beta-blockers, sex hormones, antihy-
perlipidemic and antidiabetic drugs) was made if it changed the perchlorate estimate by $10%.
Results: Statistically significant decreases were observed for HGB and HCT among boys, men, women age 15–49, and pregnant 
women, and for HDL among men.
Conclusions: Although the mean response biomarkers were within normal range, their association with urinary perchlorate is of interest. 
HGB and HCT among pregnant women showed a stronger association with urinary perchlorate than non-pregnant women age 15–49. 
Statistically significant associations were observed for individual perchlorate quintiles. Assumption of linearity of log-transformed per-
chlorate may result in underestimation of some associations.
Keywords: perchlorate, biomarkers, endocrine disruption, hypothyroidism, HDL, haemoglobin, hematocritSchreinemachers
136  Biomarker Insights 2011:6
Background
Presence of perchlorate (ClO4
−) in the environment 
is  widespread  due  to  both  natural  processes  and 
human activities.1 Exposure of humans, which occurs 
primarily  through  ingestion  of  contaminated  water 
and  food,  is  a  current  national  concern,  because 
perchlorate is a known thyroid toxicant. It prevents 
iodide from entering the thyroid, which may lead to 
diminished production of thyroid hormones. Several 
studies  have  discussed  the  risks  of  environmental 
exposures  to  perchlorate,  especially  the  potential 
adverse effects on thyroid hormone function.1–4
Urinary  perchlorate  levels  can  be  used  as  non-
invasive  surrogate  biological  markers  of  exposure, 
because perchlorate is not metabolized in the human 
body.1  Thyroid  stimulating  hormone  (TSH)  and 
thyroxine  (T4)  are  measured  as  direct  biological 
markers of effect on thyroid economy, as for example 
in newborn screening and adult testing for hypo- and 
hyperthyroidism. A recent study based on the National 
Health and Nutrition Examination Survey (NHANES) 
2001–2002, assessed associations of urinary perchlorate 
with TSH and T4.2 Results showed that increased levels 
of urinary perchlorate were associated with increased 
levels of TSH for all women, and decreased levels of 
T4 for women with low urinary iodine (,100 µg/L). 
No association was observed for men. Another study 
among women in the same NHANES 2001–2002 data 
observed that smoking and thiocyanate interact with 
perchlorate  in  diminishing  thyroid  function.3  These 
studies brought attention to the gender-specific effect 
of perchlorate on the thyroid.5
Thyroid  hormones  are  a  requisite  for  proper 
  neurodevelopment and physiological function through-
out life. Levels of thyroid hormones (THs) serve as 
direct  indicators  of  thyroid  hormone    dysfunction. 
Examples are increased levels of TSH associated with 
normal or decreased levels of T4, or decreased lev-
els of T4 without a change of TSH, which may occur 
when T4 is displaced from its binding protein by a 
  xenobiotic. Another type of disruption occurs when 
endocrine  disrupting  chemicals  displace  THs  from 
their receptors, which can change the   structure and 
the signaling of the TH receptor   without   necessarily 
changing the TH levels.5–8 Signaling pathways of dif-
ferent nuclear receptors, including TH   receptors, can 
cross-talk with each other, and disrupt the TH transcrip-
tion process with unknown biological consequences.6,7 
Chemicals that are known to cause adverse changes in 
circulating TH levels have been classified as thyroid 
toxicants.6  In  contrast,  endocrine  disrupting  chemi-
cals that cause perturbation of TH action through their 
receptors, such as signaling, without causing a change 
in TH levels, are not included in the definition of thy-
roid  toxicants.6  Given  that  environmental  pollutants 
can affect THs in different ways, it may be useful to 
investigate if in addition to the routinely used “direct” 
indicators, “  indirect” biomarkers of TH dysfunction 
can  be  identified,  in  order  to  expand  the  available 
number of biomarkers measuring the level of TH dys-
function in observational human studies. Therefore, to 
expand observations of adverse effects associated with 
TH, both changes in TH levels and TH action may 
have to be considered. The problem is how to deter-
mine  perturbation  of TH  action. Thyroid  hormones 
play an important role in many functions of the body, 
such as lipid metabolism, enzyme activity, neurologic, 
endothelial, and cardiac functions.9,10 Interference of 
TH action by environmental pollutants may adversely 
affect one or more of these systems, which may be indi-
cated by effect biomarkers, such as decreased   levels 
of HDL, HGB or HCT (“indirect” markers of thyroid 
  dysfunction). High density lipoprotein (HDL), a major 
factor in the reverse cholesterol transport (RCT) mech-
anism, removes excess cholesterol from peripheral tis-
sues to the liver for excretion.11–15 A decrease of HDL 
may indicate a perturbation of the RCT mechanism, 
the key enzymes of which are under control of TH.16,17 
The erythrocyte-related indices haemoglobin (HGB) 
and hematocrit (HCT) may be potential indicators of 
TH changes. Among subjects with overt or subclini-
cal hypothyroidism, decreased HGB and HCT have 
been observed, which are thought to be associated with 
decreased TH-controlled hematopoiesis.18–20
Because the traditionally used direct biomarkers 
of thyroid status (TSH and T4) were not associated 
with  perchlorate  among  men,2  the  purpose  of  this 
study is to investigate if HDL, HGB, and HCT are 
suitable indirect indicators of TH dysfunction among 
both men and women.
Methods
Data source and exclusion criteria
The  data  source  for  this  study  was  NHANES 
2001–2002,  one  of  several  publicly  available 
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Control  (CDC).21  The  purpose  of  these  surveys  is 
to obtain information on the nutritional and health 
status of the US general population. Because these 
datasets do not contain identifiable private informa-
tion, studies based on these data are exempt from IRB 
approval. The total number of subjects in the sub-
population selected for perchlorate analysis of spot 
urine samples was 2942 with an age range of 6–85, 
consisting of 47% males (n = 1374) and 53% females 
(n = 1568). The current study excluded subjects based 
on the following criteria: missing perchlorate values; 
previous diagnosis of diseases in which TH dysfunc-
tion  might  have  played  a  role,  such  as  congestive 
heart failure, coronary heart disease, angina pectoris, 
acute myocardial infarction, stroke, cancer, diabetes 
mellitus, thyroid problems and use of prescribed thy-
roid hormones. Values judged to be outliers, such as 
TSH . 200 IU/L, or CRP . 10 mg/dL, were also 
excluded.
Variables and statistical analyses
The analyses were applied to six groups of subjects: 
males, ages 6–19 and ages 20–85; girls, ages 6–14; 
women of reproductive age, but non-pregnant, ages 
15–49; women, ages 50–85; and pregnant women as 
determined by test. The reason for categorizing men 
and women by different age groups is the following. 
Alcohol  consumption,  which  is  an  important  vari-
able, was available only for subjects ages 20 and over. 
Therefore men were categorized by age groups ,20 
and $20, so that alcohol could be adjusted for in those 
at age 20 years and older. However, women were cat-
egorized by reproductive status, which was thought 
to be more meaningful with regard to potential asso-
ciations with perchlorate.
Regression analysis was used to assess the associ-
ation of levels of urinary perchlorate as the exposure 
surrogate with the biological measures HDL, HGB, 
and HCT. HDL was natural-log transformed in order 
to reduce skewness. HGB and HCT were approxi-
mately normally distributed. The exposure variable 
of interest, urinary perchlorate, was used in several 
ways: (1) as an indicator variable representing indi-
vidual quintiles (Q1 through Q5), with Q1 as the ref-
erent (,1.9, 1.9–3.1, 3.2–4.8, 4.9–7.3, $7.4 µg/L); 
(2) grouping of contiguous perchlorate quintiles, eg, 
combined Q2 and Q3 (Q2-3), combined Q4 and Q5 
(Q4-5), and combined Q3, Q4, and Q5 (Q3-5) with 
Q1 as the referent; and (3) continuous perchlorate 
(natural log transformed). Use of these different per-
chlorate measures allows identification of both non-
linear and linear associations.
Most of the explanatory variables selected for this 
study are the same as those used by Blount et al.2 The 
following variables were included in all regression 
analyses: age (years, continuous), urinary creatinine 
(mg/dL, continuous, log transformed); race/  ethnicity: 
non-Hispanic White (referent),   Hispanic   American, 
non-Hispanic  Black,  other  race/ethnicity;  body 
mass  index  (BMI,  continuous,  log-transformed), 
cotinine:  low,  (,0.015  ng/mL  referent),  medium 
(0.015–10 ng/mL), and high (.10 ng/mL), based on 
Steinmaus and  Miller;3  poverty index, the ratio of 
family income to poverty threshold (dichotomous, ,1 
versus $1); hours of fasting (log-  transformed, con-
tinuous),  thiocyanate  (mg/L,  continuous,  log-trans-
formed); nitrate (mg/L, continuous, log-transformed); 
daily kcal intake (continuous, log-transformed), which 
is closely related to dietary iron intake;22 C-reactive 
protein (CRP, mg/dL, continuous, log-transformed). 
Thiocyanate (mg/L) and nitrate (mg/L) were included 
because, like perchlorate, they may impair thyroid 
function by inhibiting iodide uptake by the thyroid.
Additional adjustments were made for some groups. 
Information on alcohol consumption (none, referent; 
low, 1–10 drinks per week; high, 11 or more drinks 
per week) was available only for subjects ages 20 and 
over, and was included in the regressions for men, 
age 20 and over, women age 50 and over, and women 
age 15–49 with alcohol use for the 15–19 year old set 
to “none”. Two separate indicator variables were cre-
ated for the regression analyses, indicating low alco-
hol use (1 = yes, 0 = otherwise) and high alcohol use 
(1 = yes, 0 = otherwise).   Adjustments were made for 
use of the following prescription drugs: beta blockers, 
sex hormones (contraceptives, androgens, estrogens, 
progestins),  antihyperlipidemic  agents;  antidiabetic 
agents) for men age 20 and over, women age 15–49, 
and  women  age  50  and  over.    Indicator  variables 
were created for each of the prescriptions with val-
ues 1 = yes (taking this prescription) or 0 (not taking 
this prescription). Non-pregnant women age 15–49 
were also adjusted for having been pregnant in the 
past year (1 = yes, 0 = no) and for having a men-
strual period (1 = yes, 0 = no) at time of sampling. 
  Regression analyses for girls age 6–14 were adjusted Schreinemachers
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for   menarchal status by an indicator variable with 
  values 1 (= first period had occurred before interview) 
or 0 (=   otherwise). Because no information was avail-
able for girls age 6–11, they were assumed to be pre-
menarche. Among the 12–14 year old girls, 105 out of 
167 (63%) were post-menarche. No   additional adjust-
ments were included for pregnant women because of 
their low sample size.
Laboratory methods have been described in detail 
previously.2,21 Whole blood and spot urine samples 
were collected and stored cold or frozen. HDL was 
measured  using  a  heparin-manganese  precipitation 
method. HGB and HCT were obtained from a com-
plete  blood  count  on  a  Beckman  Coulter  counter. 
Urinary  perchlorate,  thiocyanate,  and  nitrate  were 
analytically  measured  by  ion  chromatography  tan-
dem mass spectrometry.
Regression  analyses  were  performed  using  the 
SAS  procedure  PROC  SURVEYREG.23  This  pro-
cedure applies linear regression to a non-randomly 
selected study population by accounting for corre-
lations between sampling clusters and by assigning 
weights to subjects, so that outcomes are representa-
tive of the US general population. The Wilcoxon rank 
sum test was used for the comparison of the depen-
dent variables between subject groups. The Spear-
man correlation test was used to measure correlations 
between variables.
The parameter estimates β and 95% confidence 
interval (CI) represent the change of the dependent 
variable  associated  with  a  perchlorate  quintile  or 
combined quintiles for non-linear associations, or a 
unit of continuous log-transformed perchlorate, indi-
cating a linear association, with adjustment for other 
characteristics.
Results
The total number of excluded subjects was 848 due 
to:  missing  perchlorate  values  (n  =  122);  thyroid 
associated diseases (n = 489); use of prescribed thy-
roid hormones (n = 321); and TSH and CRP outli-
ers (n = 5). The remaining number of subjects was 
2094 consisting of 1010 (48%) men and 1084 (52%) 
women. Characteristics of the resulting study popula-
tion are presented in Table 1. Distribution character-
istics of urinary perchlorate for the six study groups 
are presented in Table 2. The highest perchlorate con-
centrations were observed for the younger male and 
female subjects, followed by the pregnant women. 
Table  3  presents  unadjusted  means  and  standard 
errors for the three outcome variables (HGB, HCT, 
and  HDL)  by  quintiles  of  urinary  perchlorate  for 
each of the six study groups. Although the means by 
perchlorate quintile were within normal range, both 
linear and non-linear associations with urinary per-
chlorate were observed. An example of a possible 
non-linear relationship was the decrease observed for 
HDL, which dropped at the 2nd and 3rd perchlorate 
quintile for men, age 20–85 and 6–19, respectively, 
and continued to stay at a lower level. Other variables 
showed a more direct linear decrease with increasing 
perchlorate concentration, eg, HGB and HCT among 
pregnant women.
Regression-based  associations  between  urinary 
perchlorate and the three outcome variables of inter-
est are presented in Table 4A and B.
Boys, age 6–19 (Table 4A)
The  average  level  of  association  with  HGB  and 
HCT showed a significant decrease with coefficients 
of −0.23 (−0.41, −0.04) and −0.57 (−1.10, −0.03), 
respectively. No significant association was observed 
with HDL.
Men, age 20–85 (Table 4A)
Associations with HGB and HCT were not clearly 
  linear, although the highest values were observed in 
Q5. The coefficients associated with log-transformed 
perchlorate  for  HGB  and  HCT  were  −0.18 
(−0.33, −0.02) and −0.47 −0.92, −0.01), respectively. 
The  regression  model  for  log-transformed  HDL 
showed a significant decrease based on the coefficient 
of −0.09 (−0.17, −0.01) associated with Q2-3. This 
agreed with the “drop off” observed for the unad-
justed data (Table 3). At higher concentrations of uri-
nary perchlorate HDL started to increase.
girls, age 6–14 (Table 4A)
No  significant  associations  with  perchlorate  were 
observed for HGB, HCT, or HDL.
Women, age 15–49, non-pregnant  
(Table 4B)
Among the 491 women ages 15–49 (reproductive age), 
213 (43%) were under age 20. Information on alco-
hol consumption was not available for this age group. Perchlorate and indirect indicators of thyroid dysfunction in nhAneS 2001-2002. 
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To  check  if  the  value  “no  alcohol  use”  could  be 
assigned to these women, the following analysis was 
done. Among the women age 20–49, 69% did not use 
alcohol, 27% were low alcohol users, and 4% were 
high users in the last 12 months. Regression models 
for women age 20–49 showed that the estimated effect 
of alcohol consumption on the dependent variables of 
interest in this study was no more than 1%. This, and 
the fact that alcohol consumption is either none or low 
for most women, are reasons to believe setting alco-
hol consumption for 15–19 year old women to zero 
is reasonable. The strongest decrease for HGB and 
HCT was observed in Q3, followed by an increase. 
The coefficients for HGB and HCT in Q3 were −0.67 
(−1.36, 0.02) and −2.02 (−3.74, −0.30), respectively. 
No associations were observed for HDL.
Women, age 50–85 (Table 4B)
No  associations  were  observed  for  HGB,  HCT, 
or HDL.
Pregnant women, age 16–38 (Table 4B)
In spite of the low number of observations, statistically 
significant  decreases  were  observed  for  HGB 
Table 1. characteristics of subjects.
characteristics Men (n = 1010) Women (n = 1084)
Missing (n) % Mean (se) Missing (n) % Mean (se)
Age (yrs) 
  6–19 
  20–85
 
43 
57
 
42 
58
race/ethnicity 
  Non-Hispanic White 
  non-hispanic Black 
  Hispanic American (Mexican, other) 
  Other ethnicity
 
43 
25 
28 
4
 
43 
23 
30 
4
Below poverty threshold 99 20 109 25
BMI 
  ,25 
  25–30 
  $30
66  
51 
30 
19
81  
53 
23 
23
Serum cotinine 
  Low, nondetectable, ,0.015 ng/mL 
  Medium, 0.015–10 ng/mL 
  high, .10 ng/mL
117  
15 
61 
24
135  
21 
64 
15
Use of prescription drugs 
  Beta blockers 
  Sex hormones 
  Lipid lowering drugs 
  Anti diabetic drugs
 
14 
18 
20 
14
 
15 
20 
20 
14
Alcoholic drinks/week, ages $ 20 
  none 
  1–10/week 
  .10/week
42  
52 
34 
13
84  
74 
21 
4
Other predictor variables 
  Urinary perchlorate (µg/L) 
  Urinary creatinine (mg/dL) 
  nitrate (mg/L) 
  Thiocyanate (mg/L) 
  hours of fasting 
  Daily kcal intake 
  crP (mg/dL)
 
 
 
 
 
25 
39 
68
 
5.99 (0.20) 
156.3 (2.7) 
71.23 (1.65) 
2.84 (0.10) 
9.81 (0.16) 
2509 (35) 
0.22 (0.01)
 
 
 
1 
2 
25 
45 
70
 
5.03 (0.16) 
122.5 (2.4) 
58.43 (1.40) 
2.02 (0.07) 
9.81 (0.17) 
1950 (25) 
0.32 (0.02)
Outcome variables 
  hemoglobin (g/dL) 
  hematocrit (%) 
  hDL (mg/dL)
 
59 
59 
71
 
14.95 (0.04) 
44.07 (0.13) 
48.50 (0.41)
 
58 
58 
82
 
13.27 (0.04) 
39.07 (0.10) 
55.55 (0.46)Schreinemachers
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and HCT. Coefficients for combined Q3-5 were −0.59 
(−1.01, −0.17), and −1.73 (−2.89, −0.58), for HGB 
and HCT respectively. In contrast to the non-pregnant 
women of reproductive age, estimates for the   individual 
perchlorate quintiles among pregnant women showed 
that the association between perchlorate and HGB, 
HCT was monotonic, resulting in a significant estimate 
for the overall perchlorate association. This was also 
observed  in  the  non-adjusted  data  (Table  3).  No 
significant associations were observed for HDL.
Association between direct and indirect 
indicators
To determine if direct indicators (TSH and T4) and 
indirect  indicators  (HDL,  HGB,  and  HCT)  of  TH 
disruption  were  associated,  partial  age-adjusted 
  Spearman correlations were performed for the com-
bined groups of men and the combined groups of 
women, ages 12–85 (Table 5). Thyroid hormone val-
ues were not available for those under age 12. The fol-
lowing significant correlations were observed among 
men: TSH and HDL (r = −0.070, P = 0.05); T4 and 
HGB (r = 0.093, P = 0.01); T4 and HCT (r = 0.089, 
P = 0.01). Among women,T4 and HDL were corre-
lated (r = 0.066, P = 0.05). No significant correla-
tions  were  observed  among  subjects  with  urinary 
iodine , 100 µg/L.
Table 3. Indicators of thyroid dysfunction by quintiles of urinary perchlorate (mean ± Se).
Urinary 
perchlorate
Boys 
age 6–19
Men 
age 20–85
Girls 
age 6–14
Women 
age 15–49  
not pregnant
Women 
age 50–85
Women 
age 16–38  
pregnant
hemoglobin (g/dL)
 
Q1 
Q2 
Q3 
Q4 
Q5 
mean
n = 464 
14.66 ± 0.20 
14.68 ± 0.17 
14.51 ± 0.15 
14.47 ± 0.14 
14.37 ± 0.12 
14.51 ± 0.07
n = 487 
15.53 ± 0.16 
15.38 ± 0.13 
15.51 ± 0.10 
15.32 ± 0.12 
15.18 ± 0.11 
15.38 ± 0.05
n = 300 
13.32 ± 0.17 
13.13 ± 0.16 
13.13 ± 0.14 
13.36 ± 0.11 
13.41 ± 0.10 
13.28 ± 0.06
n = 476 
13.61 ± 0.10 
13.35 ± 0.15 
13.01 ± 0.13 
13.24 ± 0.14 
13.37 ± 0.13 
13.33 ± 0.06
n = 164 
13.49 ± 0.16 
13.68 ± 0.18 
13.69 ± 0.22 
13.18 ± 0.28 
13.23 ± 0.16 
13.50 ± 0.09
n = 86 
12.71 ± 0.22 
12.67 ± 0.21 
12.39 ± 0.21 
12.43 ± 0.24 
12.12 ± 0.23 
12.48 ± 0.10
hematocrit (%)
 
Q1 
Q2 
Q3 
Q4 
Q5 
mean
n = 464 
43.38 ± 0.56 
43.16 ± 0.49 
42.82 ± 0.44 
42.53 ± 0.42 
42.30 ± 0.36 
42.73 ± 0.20
n = 487 
45.74 ± 0.45 
45.37 ± 0.37 
45.66 ± 0.27 
45.19 ± 0.35 
44.90 ± 0.31 
45.35 ± 0.15
n = 300 
39.07 ± 0.47 
38.48 ± 0.41 
38.43 ± 0.38 
39.24 ± 0.30 
39.20 ± 0.29 
38.92 ± 0.16
n = 476 
40.08 ± 0.27 
39.40 ± 0.37 
38.54 ± 0.36 
39.17 ± 0.38 
39.46 ± 0.37 
39.37 ± 0.16
n = 164 
39.72 ± 0.44 
40.28 ± 0.53 
40.63 ± 0.63 
39.11 ± 0.77 
39.09 ± 0.49 
39.86 ± 0.25
n = 86 
36.99 ± 0.58 
37.07 ± 0.62 
36.21 ± 0.48 
36.18 ± 0.67 
35.53 ± 0.72 
36.44 ± 0.28
high density lipoprotein (mg/dL)
 
Q1 
Q2 
Q3 
Q4 
Q5 
mean
n = 456 
53.16 ± 1.69 
52.62 ± 1.56 
49.08 ± 1.08 
49.49 ± 1.24 
49.01 ± 1.09 
50.18 ± 0.58
n = 483 
52.55 ± 1.89 
46.27 ± 1.28 
43.92 ± 1.01 
46.32 ± 1.13 
46.87 ± 1.19 
46.91 ± 0.58
n = 289 
49.03 ± 1.47 
51.15 ± 1.77 
50.71 ± 1.55 
51.54 ± 1.24 
50.87 ± 1.14 
50.79 ± 0.63
n = 467 
55.51 ± 1.08 
56.64 ± 1.31 
51.98 ± 1.29 
53.11 ± 1.35 
52.93 ± 1.91 
54.31 ± 0.60
n = 160 
61.81 ± 2.44 
64.39 ± 2.81 
58.93 ± 3.92 
61.18 ± 3.56 
69.00 ± 5.44 
62.69 ± 1.49
n = 86 
62.11 ± 2.87 
67.45 ± 3.69 
67.94 ± 3.61 
64.13 ± 3.82 
63.00 ± 3.29 
65.02 ± 1.54
notes: Urinary perchlorate quintiles (µg/L): Q1, ,1.9; Q2, 1.9–3.1; Q3, 3.2–4.8; Q4, 4.9–7.3; Q5, $7.4.
Table 2. Distribution of urinary perchlorate by study group.
subjects n Urinary perchlorate  
(μg/L)
Mean ± se Median
Men
  Age 6–19 501 6.20 ± 0.25 4.90
  Age 20–85 509 5.79 ± 0.31 4.20
Women
  Age 6–14 332 6.34 ± 0.33 4.80
  Age 15–49, not pregnant 491 4.33 ± 0.19 3.20
  Age 50–85 168 3.94 ± 0.31 2.70
  Age 16–38, pregnant 93 5.94 ± 0.82 3.70Perchlorate and indirect indicators of thyroid dysfunction in nhAneS 2001-2002. 
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Discussion
In addition to changes of TSH and T4 levels as direct 
indicators of TH disruption in association with per-
chlorate  exposure,  results  from  this  study  support 
the hypothesis that HDL, HGB and HCT levels may 
serve as indirect indicators. Although the means of 
these  indirect  effect  biomarkers  are  within  normal 
range (Table 3), their negative association with uri-
nary perchlorate is of interest, such as decreased HDL 
among  men  and  decreased  HGB  and  HCT  among 
both men and women. Reports have been published 
on decreased levels of HDL among subjects with sub-
clinical  hypothyroidism.7,9,11,18–20,24,25  The  herbicide 
2,4-dichlorophenoxy  acetic  acid  (2,4-D)  which  is 
known to displace T4 from its binding site on the car-
rier protein transthyretin26 and thus may be involved 
in TH dysfunction, was shown to be associated with 
decreased levels of HDL.27 Regarding associations 
between direct and indirect indicators of thyroid dys-
function, statistically significant negative associations 
have been observed between HDL and values of TSH 
within the reference range.28,29 Among older subjects, 
TSH and HGB were significantly inversely correlated 
among  those  with  hypothyroidism  and  anemia.30 
Patients with chronic stable heart failure showed that 
those  that  developed  hypothyroidism,  subclinical 
Table 4A. Markers of thyroid dysfunction and association with urinary perchlorate. regression estimates by gender and age.
Urinary perchlorate 
(quintiles and  
continuous)
estimate, 95% cI, P-value
Boys, age 6–19 Men, age 20–85 Girls, age 6–14
hemoglobin (g/dL)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 410 
  0.16 (−0.11, 0.42), P = 0.22 
−0.25 (−0.78, 0.28), P = 0.33 
−0.22 (−0.71, 0.27), P = 0.35 
−0.35 (−0.77, 0.08), P = 0.10 
−0.04 (−0.41, 0.34), P = 0.84 
−0.25 (−0.63, 0.13), P = 0.19 
−0.27 (−0.71, 0.17), P = 0.21 
−0.23 (−0.41, −0.04), P = 0.02
n = 422 
−0.20 (−0.59, 0.18), P = 0.28 
−0.18 (−0.49, 0.14), P = 0.26 
−0.14 (−0.55, 0.27), P = 0.48 
−0.46 (−0.87, −0.06), P = 0.03 
−0.18 (−0.51, 0.15), P = 0.26 
−0.30 (−0.64, 0.04), P = 0.08 
−0.23 (−0.53, 0.07), P = 0.12 
−0.18 (−0.33, −0.02), P = 0.03
n = 268 
0.21 (−0.25, 0.68), P = 0.34 
0.22 (−0.24, 0.68), P = 0.32 
0.13 (−0.39, 0.65), P = 0.59 
0.46 (−0.10, 1.01), P = 0.10 
0.18 (−0.25, 0.62), P = 0.38 
0.27 (−0.27, 0.81), P = 0.31 
0.23 (−0.24, 0.71), P = 0.31 
0.14 (−0.05, 0.33), P = 0.13
hematocrit (%)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 410 
−0.01 (−0.87, 0.86), P = 0.99 
−0.70 (−2.21, 0.82), P = 0.34 
−0.70 (−2.10, 0.69), P = 0.30 
−1.01 (−2.23, 0.21), P = 0.10 
−0.33 (−1.44, 0.78), P = 0.54 
−0.80 (−1.92, 0.33), P = 0.15 
−0.80 (−2.05, 0.46), P = 0.20 
−0.57 (−1.10, −0.03), P = 0.04
n = 422 
−0.57 (−1.66, 0.53), P = 0.29 
−0.60 (−1.46, 0.26), P = 0.16 
−0.34 (−1.51, 0.83), P = 0.55 
−1.29 (−2.41, −0.17), P = 0.03 
−0.55 (−1.45, 0.34), P = 0.21 
−0.79 (−1.77, 0.19), P = 0.11 
−0.68 (−1.48, 0.12), P = 0.09 
−0.47 (−0.92, −0.01), P = 0.04
n = 268 
0.17 (−1.29, 1.63), P = 0.81 
0.13 (−1.39, 1.65), P = 0.86 
0.30 (−1.28, 1.87), P = 0.69 
0.89 (−0.82, 2.60), P = 0.28 
0.09 (−1.30, 1.47), P = 0.90 
0.55 (−1.05, 2.16), P = 0.48 
0.33 (−1.16, 1.83), P = 0.64 
0.34 (−0.23, 0.90), P = 0.22
high density lipoprotein (mg/dL, log-transformed)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 409 
−0.01 (−0.15, 0.13), P = 0.90 
−0.03 (−0.13, 0.07), P = 0.52 
−0.02 (−0.16, 0.12), P = 0.76 
−0.03 (−0.16, 0.11), P = 0.69 
−0.02 (−0.13, 0.10), P = 0.73 
−0.02 (−0.15, 0.11), P = 0.74 
−0.03 (−0.14, 0.09), P = 0.64 
  0.01 (−0.03, 0.06), P = 0.54
n = 421 
−0.09 (−0.18, 0.00), P = 0.06 
−0.09 (−0.20, 0.01), P = 0.07 
−0.04 (−0.13, 0.05), P = 0.32 
−0.02 (−0.12, 0.09), P = 0.75 
−0.09 (−0.17, −0.01), P = 0.03 
−0.03 (−0.12, 0.06), P = 0.50 
−0.06 (−0.15, 0.03), P = 0.15 
−0.01 (−0.05, 0.04), P = 0.78
n = 264 
−0.07 (−0.20, 0.06), P = 0.26 
−0.05 (−0.15, 0.06), P = 0.36 
−0.04 (−0.14, 0.06), P = 0.39 
−0.02 (−0.15, 0.10), P = 0.69 
−0.06 (−0.14, 0.02), P = 0.13 
−0.04 (−0.13, 0.06), P = 0.44 
−0.04 (−0.13, 0.05), P = 0.33 
  0.02 (−0.04, 0.07), P = 0.57
notes: The regression coefficients associated with the individual or combined perchlorate quintiles represent the estimated average change compared to 
the first perchlorate quintile. The regression coefficients associated with log(perchlorate) represent the estimated average change per one unit increase 
of natural log-transformed perchlorate. Perchlorate effects are adjusted for age, urinary creatinine, ethnicity, cotinine, BMI, poverty index, total kcal intake, 
hours of fasting, urinary nitrates, urinary thiocyanates, crP. Additional adjustments: Men, age 20–85: alcohol consumption, prescriptions for betablocker, 
sex hormones, lipid lowering drugs, antidiabetic drugs. Girls, age 6–14: postmenarche status.Schreinemachers
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hypothyroidism, or euthyroid syndrome (normal TSH, 
decreased T3 with/without decreased T4) had lower 
HGB and HCT.31 Although in the current study sub-
jects with thyroid related diseases had been excluded, 
nevertheless  some  associations  between  direct  and 
indirect indicators were observed, such as TSH and 
HDL among men, T4 and HDL among women, T4 
and HGB, HCT among men (Table 5).
Use of HDL levels as an indirect measure of thyroid 
hormone dysfunction may not be valid for any study 
population. The purpose of this study was to investi-
gate associations with perchlorate among healthy sub-
jects, in order to observe initial effects associated with 
TH perturbation. In general, plasma concentrations of 
HDL as a measure of HDL functionality depends on 
health  status.32  The  atheroprotective  characteristics 
of HDL are based on the reverse cholesterol trans-
port mechanism (RCT), inhibition of LDL oxidation, 
and anti-inflammatory   properties. In susceptible sub-
jects, HDL may become dysfunctional, lose its RCT 
promoting and antioxidant characteristics, and even 
become pro-inflammatory. In the current study, sub-
jects with previous chronic diseases were excluded 
from the analyses. Therefore, the observed association 
between urinary perchlorate and HDL among men in 
this relatively healthy   subpopulation may reflect an 
Table 4B. Markers of thyroid dysfunction and association with urinary perchlorate. regression estimates by gender and age.
Urinary perchlorate 
(quintiles and  
continuous)
estimate, 95% cI, P-value
Women, age 15–49 
(non-pregnant)
Women, age 50–85 Women, pregnant
hemoglobin (g/dL)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 416 
−0.20 (−0.73, 0.33), P = 0.44 
−0.67 (−1.36, 0.02), P = 0.06 
−0.49 (−0.98, 0.01), P = 0.05 
  0.37 (−0.95, 0.20), P = 0.19 
−0.37 (−0.89, 0.15), P = 0.15 
−0.41 (−0.86, 0.05), P = 0.08 
−0.56 (−1.00, −0.13), P = 0.01 
−0.24 (−0.49, 0.02), P = 0.07
n = 134 
  0.09 (−0.48, 0.65), P = 0.75 
  0.10 (−0.52, 0.71), P = 0.75 
−0.35 (−1.65, 0.95), P = 0.57 
−0.75 (−2.17, 0.67), P = 0.28 
  0.11 (−0.40, 0.61), P = 0.66 
−0.51 (−1.66, 0.64), P = 0.36 
−0.09 (−0.81, 0.63), P = 0.80 
−0.22 (−0.67, 0.23), P = 0.31
n = 80 
  0.17 (−0.15, 0.48), P = 0.28 
−0.47 (−1.04, 0.12), P = 0.11 
−0.59 (−1.10, −0.08), P = 0.03 
−0.77 (−1.73, 0.18), P = 0.11 
−0.11 (−0.49, 0.28), P = 0.57 
−0.64 (−1.15, −0.14), P = 0.02 
−0.59 (−1.01, −0.17), P = 0.01 
−0.26 (−0.45, −0.08), P = 0.01
hematocrit (%)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 416 
−0.66 (−2.12, 0.79), P = 0.35 
−2.02 (−3.74, −0.30), P = 0.02 
−1.35 (−2.92, 0.21), P = 0.09 
−0.82 (−2.58, 0.94), P = 0.34 
−1.16 (−2.54, 0.23), P = 0.10 
−1.04 (−2.51, 0.44), P = 0.16 
−0.79 (−1.59, 0.01), P = 0.05 
−0.55 (−1.28, 0.18), P = 0.13
n = 134 
  0.03 (−1.41, 1.47), P = 0.96 
  0.43 (−1.13, 1.98), P = 0.57 
−1.06 (−4.59, 2.47), P = 0.53 
−2.25 (−6.28, 1.79), P = 0.25 
  0.24 (−1.05, 1.52), P = 0.70 
−1.56 (−4.85, 1.72), P = 0.33 
−0.17 (−2.14, 1.79), P = 0.85 
−0.64 (−1.97, 0.69), P = 0.32
n = 80 
  0.54 (−0.45, 1.52), P = 0.26 
−1.33 (−2.54, −0.11), P = 0.04 
−1.57 (−3.00, −0.15), P = 0.03 
−2.48 (−5.39, 0.43), P = 0.09 
−0.30 (−1.30, 0.71), P = 0.54 
−1.90 (−3.57, −0.23), P = 0.03 
−1.73 (−2.89, −0.58), P = 0.01 
−0.86 (−1.44, −0.29), P = 0.01
high density lipoprotein (mg/dL, log-transformed)
Q1 = referent 
Q2 
Q3 
Q4 
Q5 
Q2-3 
Q4-5 
Q3-5 
log(perchlorate)
n = 411 
  0.01 (−0.08, 0.09), P = 0.86 
−0.01 (−0.07, 0.06), P = 0.77 
  0.06 (−0.03, 0.15), P = 0.16 
−0.05 (−0.17, 0.07), P = 0.39 
  0.00 (−0.07, 0.07), P = 0.89 
  0.02 (−0.08, 0.11), P = 0.74 
  0.00 (−0.07, 0.07), P = 0.91 
  0.00 (−0.06, 0.07), P = 0.88
n = 132 
  0.11 (−0.02, 0.24), P = 0.09 
−0.01 (−0.15, 0.14), P = 0.93 
  0.03 (−0.17, 0.23), P = 0.75 
  0.17 (−0.08, 0.41), P = 0.17 
  0.06 (−0.04, 0.16), P = 0.22 
  0.10 (−0.09, 0.28), P = 0.29 
  0.02 (−0.11, 0.14), P = 0.78 
  0.02 (−0.07, 0.11), P = 0.64
n = 80 
  0.08 (−0.12, 0.27), P = 0.40 
  0.10 (−0.05, 0.24), P = 0.19 
  0.12 (−0.04, 0.27), P = 0.14 
−0.02 (−0.18, 0.13), P = 0.78 
  0.07 (−0.06, 0.21), P = 0.26 
  0.05 (−0.09, 0.20), P = 0.44 
  0.07 (−0.01, 0.15), P = 0.09 
  0.01 (−0.04, 0.06), P = 0.68
notes: The regression coefficients associated with the individual or combined perchlorate quintiles represent the estimated average change compared to 
the first perchlorate quintile. The regression coefficients associated with log(perchlorate) represent the estimated average change per one unit increase 
of natural log-transformed perchlorate. Perchlorate effects are adjusted for age, urinary creatinine, ethnicity, cotinine, BMI, poverty index, total kcal 
intake, hours of fasting, urinary nitrates, urinary thiocyanates, CRP. Additional adjustments: Women, age 15–49: alcohol consumption, prescriptions for 
betablocker, sex hormones, lipid lowering drugs, antidiabetic drugs, pregnancy in past year, having a period at time of sampling. Women, age 50–85: 
alcohol consumption, prescriptions for betablocker, sex hormones, lipid lowering drugs, antidiabetic drugs.Perchlorate and indirect indicators of thyroid dysfunction in nhAneS 2001-2002. 
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early indication of interference of perchlorate with 
TH action.
Unexpected results were observed for the group 
of  women  aged  50–85.  These  women  seemed  to 
be largely unaffected by perchlorate in contrast to the 
younger women. However, this assumption may be 
incorrect. A large percentage of the women in this age 
group was excluded from the study (56%, 214 out of 
382), because of previous diseases or because they 
were  prescribed  thyroid  hormones,  with  the  result 
that the 50–85 year old women remaining in the study 
were generally healthy. In comparison, the following 
percentages  were  excluded  from  the  other  groups: 
14% (52 out of 384) for girls ages 6–14; 19% (135 
out of 719) for women, ages 15–49, including preg-
nant women; 12% (71 out of 572) for boys, age 6–19; 
33% (252 out of 761) for men, age 20–85.
Comparison of the non-pregnant women of repro-
ductive age and the pregnant women based on the 
unadjusted data (Table 3) showed that with regard 
to HGB and HCT, the non-pregnant women showed 
a  U-shaped  pattern  based  on  perchlorate  quintiles, 
while  the  pregnant  women  showed  a  more  linear 
decreasing association. Before one can conclude that 
perchlorate  is  adversely  associated  with  HGB  and 
HCT among pregnant women, the following informa-
tion should be considered. It has been shown that both 
high and low maternal HGB is associated with poor 
pregnancy outcomes, such as increased rates of pre-
term births and stillbirths. The optimal values of this 
U-shaped pattern of HGB among pregnant women 
with regard to adverse birth outcomes, is represented 
by the bottom part of the “U”, with a reported range 
of 9–11 g/dL for the lowest maternal HGB recorded 
during the pregnancy, and a range of 11–13 g/dL for 
the first recorded HGB value in another study.33,34 This 
decrease in HGB is thought to be due to a healthy 
plasma volume expansion associated with pregnancy. 
Therefore, interpretation of the decreasing HGB val-
ues among pregnant women associated with perchlo-
rate becomes more complicated. A larger study group 
of pregnant women is needed to solve the question 
if perchlorate exposure is associated with enhance-
ment of the plasma volume expansion (non-adverse 
effect),  or  with  decreased  erythropoiesis  (adverse 
effect). A  recent  study  involving  pregnant  women 
only, observed that perchlorate exposure did not affect 
thyroid hormones in either euthyroid or hypothyroid 
women.35 An editorial on the impact of perchlorate 
exposure during early pregnancy speculated that per-
chlorate may have more subtle effects than changes 
of maternal thyroid hormones, or may have an effect 
on the fetus without having an effect on maternal thy-
roid hormones.36
Results  from  the  regression  analyses  showed 
that use of a continuous exposure variable, such as 
log-transformed  urinary  perchlorate,  which  repre-
sents the average population response, can be mis-
leading when the association is nonlinear. Nonlinear 
responses associated with low-dose exposures are a 
Table 5. comparison of direct (TSh, T4) and indirect (hDL, hgB, hcT) indicators of thyroid hormone disruption among 
men and women, age 12–85.
Urinary iodine Indicators spearman correlations (r), P-value (P) and number  
of subjects (n), age-adjusted
Men Women
r P n r P n
All values TSh hDL 
hgB 
hcT
−0.070 
−0.005 
−0.019
0.050 
0.890 
0.595
788 
788 
788
−0.055 
  0.024 
  0.003
0.105 
0.489 
0.932
856 
856 
856
T4 hDL 
hgB 
hcT
−0.034 
  0.093 
  0.089
0.338 
0.009 
0.012
788 
788 
788
  0.066 
−0.034 
−0.039
0.054 
0.322 
0.256
858 
858 
858
,100 µg/L TSh hDL 
hgB 
hcT
−0.057 
  0.034 
  0.034
0.483 
0.674 
0.673
153 
153 
153
−0.070 
  0.032 
  0.004
0.237 
0.591 
0.951
288 
288 
288
T4 hDL 
hgB 
hcT
  0.027 
  0.109 
  0.088
0.737 
0.182 
0.279
153 
153 
153
  0.081 
  0.056 
  0.040
0.170 
0.343 
0.505
288 
288 
288Schreinemachers
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  characteristic of hormone-like chemicals. The initial 
receptor-mediated responses are linear at low satura-
tion or occupation of the receptors. With increasing 
exposure, ie, higher receptor saturation, the effects 
weaken. No effect may be observed at the highest 
exposures. This may lead to a U- or inverted U-shaped 
response curve.37 Such nonlinear responses can be 
quantified by including a quadratic term for the expo-
sure in the regression. This allows for an increase/
decrease  of  the  response  followed  by  a  decrease/
increase at higher exposures. However, a regression 
model using exposure quantiles is easier to interpret 
and has been used in other studies. For example, an 
observational study on the association of perfluorooc-
tanoic acid on thyroid disease showed that responses 
were not necessarily linear for increasing quartiles 
of the exposure variable.38 A nonlinear association 
was observed between persistent organic pollutants 
(POPs) and type-2 diabetes.39 In this study, the second 
sextile of the combined POPs showed the strongest 
  association. To measure the response occurring at low 
levels of exposure, the referent group should be based 
on non-exposed subjects or subjects with very low 
levels of exposure. The choice of quantiles depends on 
the size of the study population. In the current study, 
for example, an association of HDL with perchlorate 
among men, ages 20–85 was observed in the non-
  adjusted data (Table 3), where a decrease in HDL was 
observed in the second and third quintiles, followed 
by an increase in the fourth and fifth quintiles. The 
adjusted data for men, ages 20–85 (Table 4A) show 
a similar pattern with stronger decreases in the 2nd 
and 3rd quintiles (−0.088 and −0.094, respectively) 
followed by weaker associations in the 4th and 5th 
quintiles. Combining the 2nd and 3rd quintiles pro-
duced statistical significance compared to the lowest 
quintile. No such association was observed when the 
lowest quartile instead of quintile was used as the 
referent.
conclusions
This cross-sectional study has generated hypotheses 
for mechanistic studies on the effects of perchlorate 
exposure.  Its  results  indicate  that  adverse  effects 
associated with perchlorate may be underestimated 
when only circulating levels of TH (direct measures) 
are considered. Additional use of indirect biomarkers, 
such as HDL, HGB, and HCT, may contribute to a 
more complete picture of initial biological responses 
to perchlorate. Future studies need to confirm these 
results in healthy subjects. The effects seen for preg-
nant women should be investigated in a larger dataset. 
In addition, use of these indirect biomarkers associ-
ated with perchlorate, should be studied in already 
compromised subjects.
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